This study is a secondary endpoint reporting the long-term recurrence free survival (RFS) and the impact of the SLN procedure on adjuvant therapies. Patients with FIGO stage I-II EC underwent pelvic SLN biopsy after cervical dual injection (technetium and patent blue) and systematic pelvic node dissection. Electronic address: report the long-term results of the SENTI-ENDO study evaluating the impact of sentinel lymph node (SLN) biopsy on management and survival in patients with early stages of endometrial cancer (EC). 10 Department of Obstetrics and Gynecology, Tenon University Hospital, Paris, France.Electronic address: 1 Department of Obstetrics and Gynecology, Tenon University Hospital, Paris, France. 9 Department of Surgical Oncology, Centre Oscar Lambret, Lille, France.8 Department of Obstetrics and Gynecology, Centre Hospitalier Lyon Sud, Lyon, France.7 Department of Surgical Oncology, Claudius Regaud Comprehensive Cancer Center, Toulouse, France.6 Department of Obstetrics and Gynecology, Bretonneau University Hospital, Tours, France.5 Department of Obstetrics and Gynecology, Edouard Herriot University Hospital, Lyon, France.4 Department of Gynecology, Poissy-Saint Germain en Laye University Hospital, Poissy, France.3 Department of Gynecology, Georges Pompidou University Hospital, Paris, France.2 Department of Obstetrics and Gynecology, Croix Rousse University Hospital, Lyon, France.1 Department of Obstetrics and Gynecology, Tenon University Hospital, Paris, France.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |